Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 450

1.

Public health and evidence-informed policy-making: The case of a commonly used herbicide.

Vainio H.

Scand J Work Environ Health. 2019 Sep 5. pii: 3851. doi: 10.5271/sjweh.3851. [Epub ahead of print]

2.

Commentary: IARC Monographs Program and public health under siege by corporate interests.

Infante PF, Melnick R, Vainio H, Huff J.

Am J Ind Med. 2018 Apr;61(4):277-281. doi: 10.1002/ajim.22811. Epub 2018 Feb 3.

PMID:
29397007
3.

Cancer Incidence in Asbestos-Exposed Workers: An Update on Four Finnish Cohorts.

Nynäs P, Pukkala E, Vainio H, Oksa P.

Saf Health Work. 2017 Jun;8(2):169-174. doi: 10.1016/j.shaw.2016.11.003. Epub 2016 Nov 20.

4.

Importance of updating old cohorts for new findings.

Vainio H, Weiderpass E.

Occup Environ Med. 2017 May;74(5):311-312. doi: 10.1136/oemed-2016-103981. Epub 2017 Jan 9. No abstract available.

PMID:
28069971
5.

Helsinki Criteria update 2014: asbestos continues to be a challenge for disease prevention and attribution.

Vainio H, Oksa P, Tuomi T, Vehmas T, Wolff H.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 1):15-9. doi: 10.19191/EP16.1S1.P015.025. No abstract available.

6.

Differences in the carcinogenic evaluation of glyphosate between the International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA).

Portier CJ, Armstrong BK, Baguley BC, Baur X, Belyaev I, Bellé R, Belpoggi F, Biggeri A, Bosland MC, Bruzzi P, Budnik LT, Bugge MD, Burns K, Calaf GM, Carpenter DO, Carpenter HM, López-Carrillo L, Clapp R, Cocco P, Consonni D, Comba P, Craft E, Dalvie MA, Davis D, Demers PA, De Roos AJ, DeWitt J, Forastiere F, Freedman JH, Fritschi L, Gaus C, Gohlke JM, Goldberg M, Greiser E, Hansen J, Hardell L, Hauptmann M, Huang W, Huff J, James MO, Jameson CW, Kortenkamp A, Kopp-Schneider A, Kromhout H, Larramendy ML, Landrigan PJ, Lash LH, Leszczynski D, Lynch CF, Magnani C, Mandrioli D, Martin FL, Merler E, Michelozzi P, Miligi L, Miller AB, Mirabelli D, Mirer FE, Naidoo S, Perry MJ, Petronio MG, Pirastu R, Portier RJ, Ramos KS, Robertson LW, Rodriguez T, Röösli M, Ross MK, Roy D, Rusyn I, Saldiva P, Sass J, Savolainen K, Scheepers PT, Sergi C, Silbergeld EK, Smith MT, Stewart BW, Sutton P, Tateo F, Terracini B, Thielmann HW, Thomas DB, Vainio H, Vena JE, Vineis P, Weiderpass E, Weisenburger DD, Woodruff TJ, Yorifuji T, Yu IJ, Zambon P, Zeeb H, Zhou SF.

J Epidemiol Community Health. 2016 Aug;70(8):741-5. doi: 10.1136/jech-2015-207005. Epub 2016 Mar 3. No abstract available.

7.

Response by the organizers of the Helsinki criteria updates 2014: Criteria for asbestos-related diseases need periodic updates.

Wolff H, Vehmas T, Oksa P, Tuomi T, Rantanen J, Vainio H.

Scand J Work Environ Health. 2016 Jan;42(1):95-6. doi: 10.5271/sjweh.3536. Epub 2015 Dec 4. No abstract available.

8.

The Need for Further Preventive Measures for Occupational Bladder Cancer.

Weiderpass E, Vainio H.

JAMA Oncol. 2015 Dec;1(9):1291-2. doi: 10.1001/jamaoncol.2015.3270. No abstract available.

PMID:
26448541
9.

Occupational safety and health in the service of people.

Vainio H.

Ind Health. 2015;53(5):387-9. doi: 10.2486/indhealth.53-387. No abstract available.

10.

European Code against Cancer 4th Edition: Environment, occupation and cancer.

Espina C, Straif K, Friis S, Kogevinas M, Saracci R, Vainio H, Schüz J.

Cancer Epidemiol. 2015 Dec;39 Suppl 1:S84-92. doi: 10.1016/j.canep.2015.03.017. Epub 2015 Jul 9.

11.

IARC monographs: 40 years of evaluating carcinogenic hazards to humans.

Pearce N, Blair A, Vineis P, Ahrens W, Andersen A, Anto JM, Armstrong BK, Baccarelli AA, Beland FA, Berrington A, Bertazzi PA, Birnbaum LS, Brownson RC, Bucher JR, Cantor KP, Cardis E, Cherrie JW, Christiani DC, Cocco P, Coggon D, Comba P, Demers PA, Dement JM, Douwes J, Eisen EA, Engel LS, Fenske RA, Fleming LE, Fletcher T, Fontham E, Forastiere F, Frentzel-Beyme R, Fritschi L, Gerin M, Goldberg M, Grandjean P, Grimsrud TK, Gustavsson P, Haines A, Hartge P, Hansen J, Hauptmann M, Heederik D, Hemminki K, Hemon D, Hertz-Picciotto I, Hoppin JA, Huff J, Jarvholm B, Kang D, Karagas MR, Kjaerheim K, Kjuus H, Kogevinas M, Kriebel D, Kristensen P, Kromhout H, Laden F, Lebailly P, LeMasters G, Lubin JH, Lynch CF, Lynge E, 't Mannetje A, McMichael AJ, McLaughlin JR, Marrett L, Martuzzi M, Merchant JA, Merler E, Merletti F, Miller A, Mirer FE, Monson R, Nordby KC, Olshan AF, Parent ME, Perera FP, Perry MJ, Pesatori AC, Pirastu R, Porta M, Pukkala E, Rice C, Richardson DB, Ritter L, Ritz B, Ronckers CM, Rushton L, Rusiecki JA, Rusyn I, Samet JM, Sandler DP, de Sanjose S, Schernhammer E, Costantini AS, Seixas N, Shy C, Siemiatycki J, Silverman DT, Simonato L, Smith AH, Smith MT, Spinelli JJ, Spitz MR, Stallones L, Stayner LT, Steenland K, Stenzel M, Stewart BW, Stewart PA, Symanski E, Terracini B, Tolbert PE, Vainio H, Vena J, Vermeulen R, Victora CG, Ward EM, Weinberg CR, Weisenburger D, Wesseling C, Weiderpass E, Zahm SH.

Environ Health Perspect. 2015 Jun;123(6):507-14. doi: 10.1289/ehp.1409149. Epub 2015 Feb 24.

12.

Epidemics of asbestos-related diseases--something old, something new.

Vainio H.

Scand J Work Environ Health. 2015 Jan;41(1):1-4. doi: 10.5271/sjweh.3471. Epub 2014 Dec 4. No abstract available.

13.

Statin use and breast cancer survival: a nationwide cohort study from Finland.

Murtola TJ, Visvanathan K, Artama M, Vainio H, Pukkala E.

PLoS One. 2014 Oct 20;9(10):e110231. doi: 10.1371/journal.pone.0110231. eCollection 2014.

14.

Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendations.

Wolff H, Vehmas T, Oksa P, Rantanen J, Vainio H.

Scand J Work Environ Health. 2015 Jan;41(1):5-15. doi: 10.5271/sjweh.3462. Epub 2014 Oct 9. No abstract available.

15.

Prevention of Occupational Diseases: Implementing the Evidence.

Verbeek J, Morata T, Ruotsalainen J, Vainio H.

Cochrane Database Syst Rev. 2013 Apr 22;6:ED000056. doi: 10.1002/14651858.ED000056. No abstract available.

PMID:
28166366
16.

The role of occupation and working in healthy ageing.

Vainio H.

Perspect Public Health. 2012 Jul;132(4):163-4. doi: 10.1177/1757913912449573. No abstract available.

PMID:
22729005
17.

Increased incidence of Merkel cell carcinoma among younger statin users.

Sahi H, Koljonen V, Böhling T, Neuvonen PJ, Vainio H, Lamminpää A, Kyyrönen P, Pukkala E.

Cancer Epidemiol. 2012 Oct;36(5):421-4. doi: 10.1016/j.canep.2012.05.006. Epub 2012 Jun 7.

PMID:
22683172
18.

Genetic polymorphisms of xenobiotic-metabolizing enzymes influence the risk of pulmonary emphysema.

Kukkonen MK, Hämäläinen S, Kaleva S, Vehmas T, Huuskonen MS, Oksa P, Vainio H, Piirilä P, Hirvonen A.

Pharmacogenet Genomics. 2011 Dec;21(12):876-83. doi: 10.1097/FPC.0b013e32834d597f.

PMID:
22027651
19.

[Health risks of engineered nanomaterials and nanotechnologies].

Savolainen K, Vainio H.

Duodecim. 2011;127(11):1097-104. Review. Finnish.

PMID:
21755801
20.

Towards better work and well-being: an overview.

Anttonen H, Vainio H.

J Occup Environ Med. 2010 Dec;52(12):1245-8. doi: 10.1097/JOM.0b013e318202f3bd.

PMID:
21750472
21.

Risk factors for breast cancer, including occupational exposures.

Weiderpass E, Meo M, Vainio H.

Saf Health Work. 2011 Mar;2(1):1-8. doi: 10.5491/SHAW.2011.2.1.1. Epub 2011 Mar 31.

22.

Protein adducts as biomarkers of exposure to aromatic diisocyanates in workers manufacturing polyurethane (PUR) foam.

Säkkinen K, Tornaeus J, Hesso A, Hirvonen A, Vainio H, Norppa H, Rosenberg C.

J Environ Monit. 2011 Apr;13(4):957-65. doi: 10.1039/c0em00595a. Epub 2011 Feb 23.

PMID:
21344094
23.

Proteomic detection of cancer in asbestosis patients using SELDI-TOF discovered serum protein biomarkers.

Tooker BC, Newman LS, Bowler RP, Karjalainen A, Oksa P, Vainio H, Pukkala E, Brandt-Rauf PW.

Biomarkers. 2011 Mar;16(2):181-91. doi: 10.3109/1354750X.2010.543289. Epub 2011 Jan 14.

PMID:
21231887
24.

Genetic susceptibility to asbestos-related fibrotic pleuropulmonary changes.

Kukkonen MK, Hämäläinen S, Kaleva S, Vehmas T, Huuskonen MS, Oksa P, Vainio H, Piirilä P, Hirvonen A.

Eur Respir J. 2011 Sep;38(3):672-8. doi: 10.1183/09031936.00049810. Epub 2010 Sep 16.

25.

Well-being at work--overview and perspective.

Schulte P, Vainio H.

Scand J Work Environ Health. 2010 Sep;36(5):422-9. Epub 2010 Aug 5. Review.

26.

Epidemiology, public health, and the rhetoric of false positives.

Blair A, Saracci R, Vineis P, Cocco P, Forastiere F, Grandjean P, Kogevinas M, Kriebel D, McMichael A, Pearce N, Porta M, Samet J, Sandler DP, Costantini AS, Vainio H.

Environ Health Perspect. 2009 Dec;117(12):1809-13. doi: 10.1289/ehp.0901194. Epub 2009 Oct 7.

27.

Serum growth factors in asbestosis patients.

Li Y, Karjalainen A, Koskinen H, Vainio H, Pukkala E, Hemminki K, Brandt-Rauf PW.

Biomarkers. 2009 Feb;14(1):61-6. doi: 10.1080/13547500802676868.

PMID:
19283526
28.

Sharpening the focus on occupational safety and health in nanotechnology.

Schulte P, Geraci C, Zumwalde R, Hoover M, Castranova V, Kuempel E, Murashov V, Vainio H, Savolainen K.

Scand J Work Environ Health. 2008 Dec;34(6):471-8.

29.

Leadership, job well-being, and health effects--a systematic review and a meta-analysis.

Kuoppala J, Lamminpää A, Liira J, Vainio H.

J Occup Environ Med. 2008 Aug;50(8):904-15. doi: 10.1097/JOM.0b013e31817e918d.

PMID:
18695449
30.

Genetics and occupational health and safety.

Vainio H.

Occup Environ Med. 2007 Nov;64(11):721-2. No abstract available.

31.

Työterveyslääkärin osaaminen.

Vainio H.

Duodecim. 2007;123(6):707-8. Finnish. No abstract available.

PMID:
17612139
32.

CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population.

Sillanpää P, Heikinheimo L, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Metsola K, Hirvonen A.

Breast Cancer Res Treat. 2007 Sep;104(3):287-97. Epub 2006 Oct 25.

PMID:
17063266
33.

Polycyclic aromatic hydrocarbon (PAH) metabolizing enzyme activities in human lung, and their inducibility by exposure to naphthalene, phenanthrene, pyrene, chrysene, and benzo(a)pyrene as shown in the rat lung and liver.

Elovaara E, Mikkola J, Stockmann-Juvala H, Luukkanen L, Keski-Hynnilä H, Kostiainen R, Pasanen M, Pelkonen O, Vainio H.

Arch Toxicol. 2007 Mar;81(3):169-82. Epub 2006 Aug 12.

PMID:
16906435
34.

Fruit and vegetables in cancer prevention.

Vainio H, Weiderpass E.

Nutr Cancer. 2006;54(1):111-42. Review.

PMID:
16800779
35.

Distribution of glutathione S-transferase M1, P1 and T1 genotypes in different age-groups of Finns without diagnosed cancer.

Voho A, Impivaara O, Järvisalo J, Metsola K, Vainio H, Hirvonen A.

Cancer Detect Prev. 2006;30(2):144-51. Epub 2006 Apr 25.

PMID:
16638627
36.

Scientific misconduct--is there a need for policing the profession?

Vainio H.

Scand J Work Environ Health. 2006 Feb;32(1):85-6. No abstract available.

37.

Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women.

Sillanpää P, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K, Hirvonen A.

Pharmacogenet Genomics. 2005 Oct;15(10):749-52.

PMID:
16141802
38.
39.

From hazard identification to weighing the benefits and drawbacks of prevention.

Vainio H, Weiderpass E.

Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):28-33. Review.

PMID:
16005922
40.

EPHX1 gene polymorphisms and individual susceptibility to lung cancer.

Voho A, Metsola K, Anttila S, Impivaara O, Järvisalo J, Vainio H, Husgafvel-Pursiainen K, Hirvonen A.

Cancer Lett. 2006 Jun 8;237(1):102-8. Epub 2005 Jul 7.

PMID:
16005144
41.

Molecular epidemiology: convergence between toxicology and epidemiology.

Hayes RB, Husgafvel-Pursiainen K, Vainio H.

Mutat Res. 2005 Dec 30;592(1-2):1-2. Epub 2005 Jul 1. No abstract available.

PMID:
15993432
42.

NAT2 slow acetylator genotype as an important modifier of breast cancer risk.

Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K.

Int J Cancer. 2005 Apr 20;114(4):579-84.

43.

Workgroup I: criteria for screening. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002).

Boyle P, Vainio H, Smith R, Benamouzig R, Lee WC, Segnan N, Takima K, Tsubono Y.

Ann Oncol. 2005 Jan;16(1):25-30. No abstract available.

PMID:
15598932
44.

Isothiocyanates in cancer prevention.

Bianchini F, Vainio H.

Drug Metab Rev. 2004 Oct;36(3-4):655-67. Review.

PMID:
15554241
45.

p53 autoantibodies predict subsequent development of cancer.

Li Y, Karjalainen A, Koskinen H, Hemminki K, Vainio H, Shnaidman M, Ying Z, Pukkala E, Brandt-Rauf PW.

Int J Cancer. 2005 Mar 10;114(1):157-60.

46.

A prospective study of body size in different periods of life and risk of premenopausal breast cancer.

Weiderpass E, Braaten T, Magnusson C, Kumle M, Vainio H, Lund E, Adami HO.

Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1121-7.

47.

Building an evidence base for occupational health interventions.

Verbeek J, Husman K, van Dijk F, Jauhiainen M, Pasternack I, Vainio H.

Scand J Work Environ Health. 2004 Apr;30(2):164-70.

PMID:
15127785
48.

Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk.

Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K.

Pharmacogenetics. 2004 Apr;14(4):239-45.

PMID:
15083068
49.

Methods and Economic Considerations: Group 1 Report. ESGE/UEGF Colorectal Cancer--Public Awareness Campaign. The Public/Professional Interface Workshop: Oslo, Norway, June 20 - 22, 2003. fulfillment corporate.

Steele RJ, Gnauck R, Hrcka R, Kronborg O, Kuntz C, Moayyedi P, O'Morain C, Spicák J, Vainio H.

Endoscopy. 2004 Apr;36(4):349-53. No abstract available.

PMID:
15057689
50.

[Overweight and physical inactivity can increase the risk of cancer. Evident connection in the most common cancer types].

Terry J, Terry P, Weiderpass E, Vainio H.

Lakartidningen. 2004 Mar 4;101(10):894-6. Review. Swedish. No abstract available.

PMID:
15055051

Supplemental Content

Loading ...
Support Center